Low-molecular-weight heparin for the prevention and treatment of placenta-mediated pregnancy complications: The tides have shifted

Thromb Res. 2018 Oct:170:207-208. doi: 10.1016/j.thromres.2018.09.045. Epub 2018 Sep 11.

Author

Leslie Skeith¹

Affiliation

¹ Division of Hematology and Hematological Malignancies, Department of Medicine, University of Calgary, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada. Electronic address: laskeith@ucalgary.ca.

PMID: 30219198
DOI: 10.1016/j.thromres.2018.09.045

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants
Female
Heparin
Heparin, Low-Molecular-Weight*
Humans
Placenta*
Pregnancy
Pregnancy Complications
Pregnancy Complications, Hematologic

Substances

Anticoagulants
Heparin, Low-Molecular-Weight
Heparin